Thomas B. Neff, Chief Executive Officer at FIBROGEN INC (FGEN), sold 39,636 shares at $55.14 ($2.2M) on 2019-03-20, disclosed to the SEC on 2019-03-22.
Seasonal sale ($2.2M) by Chief Executive Officer — this insider has traded FGEN in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.09 | 428 | $24K | 1.1% |
| 2 | $55.14 | 11,134 | $614K | 27.9% |
| 3 | $55.83 | 7,266 | $406K | 18.4% |
| 4 | $55.83 | 990 | $55K | 2.5% |
| 5 | $55.37 | 9,642 | $534K | 24.3% |
| 6 | $55.83 | 1,418 |
| $79K |
| 3.6% |
| 7 | $55.85 | 8,758 | $489K | 22.2% |
| Total | $55.52 avg | 39,636 | $2.2M | 100% |
| Filing → |
| FGEN | SELL | 2019-07-26 | $1.9M | — | Filing → |
| FGEN | SELL | 2019-07-12 | $1.8M | — | Filing → |
| FGEN | SELL | 2019-06-21 | $1.8M | — | Filing → |